ANAPTYSBIO, INC sold TRAX
April 20, 2026 · Form 4 insider transaction
ANAPTYSBIO, INC sold 100 shares of First Tracks Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
On April 1, 2026, AnaptysBio, Inc., a Delaware corporation ("AnaptysBio"), reported that it owned 100 shares of common stock, par value $0.001 per share, of First Tracks Biotherapeutics, Inc. ("First Tracks"), which at the time constituted all of the issued and outstanding shares of common stock of First Tracks.; The record date for the distribution by AnaptysBio of all shares of common stock of First Tracks to the holders of AnaptysBio common stock was April 20, 2026 (the "Spin-Off"). The Spin-Off occurred before the market opened on April 20, 2026.; Represents the outstanding shares of common stock of First Tracks as of April 20, 2026, which were distributed in the Spin-Off as defined in footnote 2 on April 20, 2026.